Farrow Jeffrey S

CIK 00014052535 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001405253

Recent Transactions

50 trades

Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-03-05+19,306→ 19,306 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2026-03-05+30,724→ 30,724 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-06-17$40.42/sh−13,608→ 36,704 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-06-16+27,881→ 50,312 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-06-16−27,881→ 55,763 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-20$50.11/sh−1,186→ 22,431 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-19$47.40/sh−1,254→ 23,617 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-18$46.29/sh−1,284→ 24,871 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-17−8,019→ 24,060 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-15+8,019→ 26,155 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-05+20,089→ 20,089 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2025-03-05+30,628→ 30,628 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-06-18$27.47/sh−10,445→ 18,136 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-06-17−27,881→ 83,644 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-06-17+27,881→ 28,581 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-07+32,079→ 32,079 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2024-03-07+47,500→ 47,500 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-04-24+111,525→ 111,525 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2023-04-24+163,397→ 163,397 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−42,400→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−120,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−15,460→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−3,125→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−26,739→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−10,299→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−9,060→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−28,628→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−38,500→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−38,739→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−13,814→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−40,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−35,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−26,454→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-27−23,653→ 10,299 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-27$16.40/sh+23,653→ 26,739 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01$68.15/sh−1,885→ 34,527 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+2,763→ 34,204 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−2,208→ 15,460 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−2,763→ 13,814 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01$68.00/sh−31,441→ 3,086 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+2,208→ 36,412 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-08-01−3,125→ 3,125 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-08-01−3,020→ 9,060 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-08-01+6,145→ 33,567 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-08-01$32.40/sh−2,126→ 31,441 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to buy)
2022-03-01+28,628→ 28,628 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01+17,668→ 17,668 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01+17,668→ 17,668 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01−2,763→ 16,577 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-03-01$29.87/sh−1,315→ 27,422 total

Companies

Recent Filings

Address

C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160

IRVINE, CA, 92618

View on SEC.gov